z-logo
open-access-imgOpen Access
Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study
Author(s) -
Anthony J. Swerdlow,
Rosie Cooke,
Dominique Beckers,
Birgit Borgström,
Gary Butler,
JeanClaude Carel,
Stefano Cianfarani,
Peter Clayton,
J Coste,
Annalisa Deodati,
Emmanuel Écosse,
Ruth Gausche,
Claudio Giacomozzi,
Anita Hokken-Koelega,
Aysha J. Khan,
Wieland Kieß,
Claudia E. Kuehni,
Primus-E. Mullis,
Roland Pfäffle,
Lars Sävendahl,
Grit Sommer,
Muriel Thomas,
Anders Tidblad,
Sally Tollerfield,
Liesbet Van Eycken,
Gladys R.J. Zandwijken
Publication year - 2017
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2016-2046
Subject(s) - medicine , cancer , cohort , incidence (geometry) , population , bladder cancer , standardized mortality ratio , oncology , cohort study , environmental health , physics , optics
Growth hormone (GH) is prescribed for an increasing range of indications, but there has been concern that it might raise cancer risk. Published data are limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom